Celularity Inc. (Nasdaq: CELU) (the “Company”), a regenerative medicine company developing and commercializing placental-derived technologies, today announced that it has received a formal notice from ...

The development has the potential to enhance safety and minimize environmental impact, according to researchers. During oil ...

The global tissue engineered skin substitute market is expected to reach a value of USD 2.4 billion in 2024, with projections indicating a growth to USD 3.5 billion by 2034. The market is anticipated ...

Geoffrey Lomax, DrPH, joined the California Institute for Regenerative Medicine in 2005. He is the Associate Director for ...

Bioprinting will enable on-site organ and tissue production, supporting healthier, longer-lasting human presence in space and ...

Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound(TM) Product from Sequence LifeScience, Inc.

FLORHAM PARK, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, today announced that it had added to its commercial portfolio of ...

Scientists from TPU Research School of Chemistry and Applied Biomedical Sciences in collaboration with Russian and ...

Applied across various levels of complexity, stem cell bioengineering holds promise in tackling current challenges and advancing regenerative medicine ... techniques aimed at enhancing the therapeutic ...

Adoption of novel biomaterials and scaffolds improves cell culture conditions and supports advanced tissue engineering ...

RTI Surgical Announces Agreement to Acquire Collagen Solutions Further expands RTI’s soft tissue portfolio of xenograft and allograft materials ...

We INFORM. We INSPIRE. We EMPOWER. Founded by serial entrepreneur Sonalie Figueiras in 2011, Green Queen is a multi-channel digital news platform and a trusted global impact media brand. Our ...